My name is Zoe James. I had back-to-back fertility treatment for 3 years. I’m now 44, recently single with no biological children. I spend my time between London and the north east of England where I teach pregnancy yoga and hypnobirthing and soon I will be running workshops helping women to heal from their IVF…
Read more
My name is Chris. I began the IVF process at age 39 and stopped after two rounds at age 41. I am a high school teacher who loves to travel and aspires to be a writer. Since 2011, I’ve traveled to 21 states and 12 countries. I live in Connecticut with my three dogs, farm…
Read more
In the year leading to the 40th anniversary of the first in vitro fertilization (IVF) birth, and as the ReproTech industry continues to grow (IVF market projected to reach $26B by 2022), we share the untold stories. Here’s one that reveals how clinics try to capture new leads. I stumbled upon your [Silent Sorority] blog…
Read more
Different Shores blogs from Dublin, Ireland. She has raised questions about clinic business motives and explains how data obfuscation interferes with informed decision-making, noting: “When you are starting out you hit up the online message boards, ask around and hope for the best.” She shares her IVF experience in the following essay for our #UnmaskingIVF campaign.…
Read more
ReproTech patients gather in a first-of-its-kind forum to discuss the complex emotional burden of failed ReproTech treatment and the loss of parenthood. In a raw and honest exchange, you’ll hear women underscore the importance of compassion and camaraderie. They explore the multi-dimensional personal-socio-cultural dynamics that come in the wake of failed IVF. Among the topics…
Read more
Investigative journalist Jonathan Jones devoted almost two years of research to the IVF industry and its practices for the Center for Investigative Research. He was joined a year into the project by Bernice Yeung. Together, they completed several reports and a 50-minute podcast. They also talked to PBS affiliates about their findings. In answer to…
Read more
Comments